PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 47 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,842,000 | +26.9% | 600,000 | -44.0% | 0.03% | +11.1% |
| Q3 2020 | $10,912,000 | -47.5% | 1,071,946 | -23.2% | 0.03% | -49.1% |
| Q2 2020 | $20,803,000 | +244.0% | 1,396,169 | +181.4% | 0.05% | +194.4% |
| Q1 2020 | $6,048,000 | -23.0% | 496,169 | 0.0% | 0.02% | -5.3% |
| Q4 2019 | $7,854,000 | +24.9% | 496,169 | -3.1% | 0.02% | +26.7% |
| Q3 2019 | $6,289,000 | -25.0% | 512,169 | -19.4% | 0.02% | -28.6% |
| Q2 2019 | $8,386,000 | – | 635,327 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|